{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:48:28Z","timestamp":1740134908396,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004435","name":"Association for International Cancer Research","doi-asserted-by":"publisher","award":["03-252"],"award-info":[{"award-number":["03-252"]}],"id":[{"id":"10.13039\/100004435","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12881-016-0337-8","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T12:52:21Z","timestamp":1476276741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["No association between TGF-\u03b21 polymorphisms and risk of nasopharyngeal carcinoma in a large North African case-control study"],"prefix":"10.1186","volume":"17","author":[{"given":"Wafa","family":"Khaali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Moumad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El Khalil","family":"Ben Driss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdellatif","family":"Benider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wided","family":"Ben Ayoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mokhtar","family":"Hamdi-Cherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kada","family":"Boualga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Hassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilys","family":"Corbex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meriem","family":"Khyatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,12]]},"reference":[{"key":"337_CR1","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(05)66698-6","volume":"365","author":"WI Wei","year":"2005","unstructured":"Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005;365:2041\u201354.","journal-title":"Lancet"},{"key":"337_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0973-1482.48763","volume":"5","author":"S Afqir","year":"2009","unstructured":"Afqir S, Ismaili N, Errihani H. Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: current status. J Cancer Res Ther. 2009;5:3\u20137.","journal-title":"J Cancer Res Ther"},{"key":"337_CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.anl.2011.02.012","volume":"39","author":"T Yoshizaki","year":"2012","unstructured":"Yoshizaki T, Ito M, Murono S, et al. Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx. 2012;39:137\u201344.","journal-title":"Auris Nasus Larynx"},{"key":"337_CR4","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.bjc.6605281","volume":"101","author":"BJ Feng","year":"2009","unstructured":"Feng BJ, Khyatti M, Ben-Ayoub W, et al. Cannabis, tobacco and domestic fumes intake are associated with nasopharyngeal carcinoma in North Africa. Br J Cancer. 2009;101:1207\u201312.","journal-title":"Br J Cancer"},{"key":"337_CR5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5732\/cjc.010.10609","volume":"30","author":"MJ Simons","year":"2011","unstructured":"Simons MJ. Nasopharyngeal carcinoma as a paradigm of cancer genetics. Chin J Cancer. 2011;30:79\u201384.","journal-title":"Chin J Cancer"},{"key":"337_CR6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1365-2273.2001.00449.x","volume":"26","author":"AL McDermott","year":"2001","unstructured":"McDermott AL, Dutt SN, Watkinson JC. The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci. 2001;26:82\u201392.","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"337_CR7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1044579X02000858","volume":"12","author":"MC Yu","year":"2002","unstructured":"Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421\u20139.","journal-title":"Semin Cancer Biol"},{"key":"337_CR8","first-page":"29","volume":"11","author":"KR Wei","year":"2010","unstructured":"Wei KR, Yu YL, Yang YY, et al. Epidemiological trends of nasopharyngeal carcinoma in China. Asian Pac J Cancer Prev. 2010;11:29\u201332.","journal-title":"Asian Pac J Cancer Prev"},{"key":"337_CR9","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/S0959-8049(03)00367-8","volume":"39","author":"J Spano","year":"2003","unstructured":"Spano J, Busson P, Atlan D, et al. Nasopharyngeal carcinomas: an update. Eur J Cancer. 2003;39:2121\u201335.","journal-title":"Eur J Cancer"},{"key":"337_CR10","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1158\/1055-9965.EPI-08-0461","volume":"17","author":"F Bray","year":"2008","unstructured":"Bray F, Haugen M, Moger TA, et al. Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol Biomarkers Prev. 2008;17:2356\u201365.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"337_CR11","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","volume":"331","author":"WA Border","year":"1994","unstructured":"Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331:1286\u201392.","journal-title":"N Engl J Med"},{"key":"337_CR12","first-page":"21","volume":"1775","author":"K Pardali","year":"2007","unstructured":"Pardali K, Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta. 2007;1775:21\u201362.","journal-title":"Biochim Biophys Acta"},{"key":"337_CR13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massague","year":"2008","unstructured":"Massague J. TGFbeta in cancer. Cell. 2008;134:215\u201330.","journal-title":"Cell"},{"key":"337_CR14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF01570787","volume":"12","author":"D Fujii","year":"1986","unstructured":"Fujii D, Brissenden JE, Derynck R, Francke U. Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet. 1986;12:281\u20138.","journal-title":"Somat Cell Mol Genet"},{"key":"337_CR15","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1093\/nar\/15.7.3188","volume":"15","author":"R Derynck","year":"1987","unstructured":"Derynck R, Rhee L, Chen EY, Van Tilburg A. Intron-exon structure of the human transforming growth factor-beta precursor gene. Nucleic Acids Res. 1987;15:3188\u20139.","journal-title":"Nucleic Acids Res"},{"key":"337_CR16","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ijrobp.2007.05.023","volume":"70","author":"CA Peters","year":"2008","unstructured":"Peters CA, Stock RG, Cesaretti JA, et al. TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:752\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"337_CR17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1756-9966-28-94","volume":"28","author":"X Guan","year":"2009","unstructured":"Guan X, Zhao H, Niu J, et al. Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. J Exp Clin Cancer Res. 2009;28:94\u20139966. 28-94.","journal-title":"J Exp Clin Cancer Res"},{"key":"337_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2005.11.016","volume":"52","author":"HG Kang","year":"2006","unstructured":"Kang HG, Chae MH, Park JM, et al. Polymorphisms in TGF-beta1 gene and the risk of lung cancer. Lung Cancer. 2006;52:1\u20137.","journal-title":"Lung Cancer"},{"key":"337_CR19","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/1078-0432.CCR-09-2877","volume":"16","author":"X Guan","year":"2010","unstructured":"Guan X, Sturgis EM, Lei D, et al. Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer. Clin Cancer Res. 2010;16:1416\u201322.","journal-title":"Clin Cancer Res"},{"key":"337_CR20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/carcin\/bgg197","volume":"25","author":"Z Li","year":"2004","unstructured":"Li Z, Habuchi T, Tsuchiya N, et al. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10. Carcinogenesis. 2004;25:237\u201340.","journal-title":"Carcinogenesis"},{"key":"337_CR21","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1158\/1055-9965.EPI-05-0078","volume":"14","author":"A Shin","year":"2005","unstructured":"Shin A, Shu XO, Cai Q, et al. Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages. Cancer Epidemiol Biomarkers Prev. 2005;14:1567\u201370.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"337_CR22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejca.2006.08.021","volume":"43","author":"AM Gonzalez-Zuloeta Ladd","year":"2007","unstructured":"Gonzalez-Zuloeta Ladd AM, Arias-Vasquez A, Siemes C, et al. Transforming-growth factor beta1 Leu10Pro polymorphism and breast cancer morbidity. Eur J Cancer. 2007;43:371\u20134.","journal-title":"Eur J Cancer"},{"key":"337_CR23","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/00007890-199810270-00009","volume":"66","author":"MR Awad","year":"1998","unstructured":"Awad MR, El-Gamel A, Hasleton P, et al. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation. 1998;66:1014\u201320.","journal-title":"Transplantation"},{"key":"337_CR24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/hmg\/8.1.93","volume":"8","author":"DJ Grainger","year":"1999","unstructured":"Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet. 1999;8:93\u20137.","journal-title":"Hum Mol Genet"},{"key":"337_CR25","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00042737-200012120-00011","volume":"12","author":"AJ Bathgate","year":"2000","unstructured":"Bathgate AJ, Pravica V, Perrey C, et al. Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease. Eur J Gastroenterol Hepatol. 2000;12:1329\u201333.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"337_CR26","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.5858\/2003-127-1480-GFARIJ","volume":"127","author":"PJ Zhang","year":"2003","unstructured":"Zhang PJ, Weber R, Liang HH, et al. Growth factors and receptors in juvenile nasopharyngeal angiofibroma and nasal polyps: an immunohistochemical study. Arch Pathol Lab Med. 2003;127:1480\u20134.","journal-title":"Arch Pathol Lab Med"},{"key":"337_CR27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jjco\/hyi126","volume":"35","author":"HW Chen","year":"2005","unstructured":"Chen HW, Chang YC, Lai YL, et al. Change of plasma transforming growth factor-beta1 levels in nasopharyngeal carcinoma patients treated with concurrent chemo-radiotherapy. Jpn J Clin Oncol. 2005;35:427\u201332.","journal-title":"Jpn J Clin Oncol"},{"key":"337_CR28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijporl.2005.06.007","volume":"70","author":"G Saylam","year":"2006","unstructured":"Saylam G, Yucel OT, Sungur A, Onerci M. Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol. 2006;70:227\u201334.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"337_CR29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cca.2007.02.008","volume":"380","author":"YS Wei","year":"2007","unstructured":"Wei YS, Zhu YH, Du B, et al. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. Clin Chim Acta. 2007;380:165\u20139.","journal-title":"Clin Chim Acta"},{"key":"337_CR30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/0194599811434890","volume":"146","author":"S Hu","year":"2012","unstructured":"Hu S, Zhou G, Zhang L, et al. The effects of functional polymorphisms in the TGFbeta1 gene on nasopharyngeal carcinoma susceptibility. Otolaryngol Head Neck Surg. 2012;146:579\u201384.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"337_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2123-6","author":"YL Qu","year":"2014","unstructured":"Qu YL, Yu H, Chen YZ, et al. Relationships between genetic polymorphisms in inflammation-related factor gene and the pathogenesis of nasopharyngeal cancer. Tumour Biol. 2014. doi: 10.1007\/s13277-014-2123-6 .","journal-title":"Tumour Biol"},{"key":"337_CR32","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/ijc.22813","volume":"121","author":"BJ Feng","year":"2007","unstructured":"Feng BJ, Jalbout M, Ayoub WB, et al. Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries. Int J Cancer. 2007;121:1550\u20135.","journal-title":"Int J Cancer"},{"key":"337_CR33","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nrc1208","volume":"3","author":"PM Siegel","year":"2003","unstructured":"Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer. 2003;3:807\u201321.","journal-title":"Nat Rev Cancer"},{"key":"337_CR34","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1003::AID-CNCR1>3.0.CO;2-F","volume":"82","author":"AT Chan","year":"1998","unstructured":"Chan AT, Teo PM, Leung TW, Johnson PJ. The role of chemotherapy in the management of nasopharyngeal carcinoma. Cancer. 1998;82:1003\u201312.","journal-title":"Cancer"},{"key":"337_CR35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1535-6108(04)00119-9","volume":"5","author":"KW Lo","year":"2004","unstructured":"Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell. 2004;5:423\u20138.","journal-title":"Cancer Cell"},{"key":"337_CR36","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1478-3231.2005.01150.x","volume":"25","author":"J Oliver","year":"2005","unstructured":"Oliver J, Agundez JA, Morales S, et al. Polymorphisms in the transforming growth factor-beta gene (TGF-beta) and the risk of advanced alcoholic liver disease. Liver Int. 2005;25:935\u20139.","journal-title":"Liver Int"},{"key":"337_CR37","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1034\/j.1398-9995.2001.00373.x","volume":"56","author":"D Buckova","year":"2001","unstructured":"Buckova D, Izakovicova Holla L, Benes P, et al. TGF-beta1 gene polymorphisms. Allergy. 2001;56:1236\u20137.","journal-title":"Allergy"},{"key":"337_CR38","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/cs0950659","volume":"95","author":"P Syrris","year":"1998","unstructured":"Syrris P, Carter ND, Metcalfe JC, et al. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond). 1998;95:659\u201367.","journal-title":"Clin Sci (Lond)"},{"key":"337_CR39","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00439-001-0617-y","volume":"109","author":"LJ Pulleyn","year":"2001","unstructured":"Pulleyn LJ, Newton R, Adcock IM, Barnes PJ. TGFbeta1 allele association with asthma severity. Hum Genet. 2001;109:623\u20137.","journal-title":"Hum Genet"},{"key":"337_CR40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/emm.2003.27","volume":"35","author":"YJ Kim","year":"2003","unstructured":"Kim YJ, Lee HS, Im JP, et al. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med. 2003;35:196\u2013202.","journal-title":"Exp Mol Med"},{"key":"337_CR41","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cyto.2008.08.008","volume":"44","author":"E Falleti","year":"2008","unstructured":"Falleti E, Fabris C, Toniutto P, et al. TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer. Cytokine. 2008;44:256\u201361.","journal-title":"Cytokine"},{"key":"337_CR42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0304-3835(03)00468-3","volume":"201","author":"P Krippl","year":"2003","unstructured":"Krippl P, Langsenlehner U, Renner W, et al. The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk. Cancer Lett. 2003;201:181\u20134.","journal-title":"Cancer Lett"},{"key":"337_CR43","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/ijc.22443","volume":"120","author":"G Jin","year":"2007","unstructured":"Jin G, Wang L, Chen W, et al. Variant alleles of TGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population. Int J Cancer. 2007;120:1330\u20135.","journal-title":"Int J Cancer"},{"key":"337_CR44","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1440-1746.2008.05324.x","volume":"23","author":"T Li","year":"2008","unstructured":"Li T, Cao BW, Dai Y, et al. Correlation of transforming growth factor beta-1 gene polymorphisms C-509T and T869C and the risk of gastric cancer in China. J Gastroenterol Hepatol. 2008;23:638\u201342.","journal-title":"J Gastroenterol Hepatol"},{"key":"337_CR45","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1399-0039.2007.00935.x","volume":"70","author":"YS Wei","year":"2007","unstructured":"Wei YS, Xu QQ, Wang CF, et al. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma. Tissue Antigens. 2007;70:464\u20139.","journal-title":"Tissue Antigens"},{"key":"337_CR46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00432-007-0290-1","volume":"134","author":"G Jin","year":"2008","unstructured":"Jin G, Deng Y, Miao R, et al. TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a Chinese population. J Cancer Res Clin Oncol. 2008;134:345\u201351.","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-016-0337-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T05:25:22Z","timestamp":1657430722000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-016-0337-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,12]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["337"],"URL":"https:\/\/doi.org\/10.1186\/s12881-016-0337-8","relation":{},"ISSN":["1471-2350"],"issn-type":[{"type":"electronic","value":"1471-2350"}],"subject":[],"published":{"date-parts":[[2016,10,12]]},"article-number":"72"}}